| 4.22 1.01 (31.46%) | 08-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.53 |
1-year : | 6.46 |
| Resists | First : | 4.73 |
Second : | 5.53 |
| Pivot price | 3.56 |
|||
| Supports | First : | 3.66 |
Second : | 3 |
| MAs | MA(5) : | 3.74 |
MA(20) : | 3.54 |
| MA(100) : | 4.73  |
MA(250) : | 7.4 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 27.9 |
D(3) : | 36.7 |
| RSI | RSI(14): 56.8 |
|||
| 52-week | High : | 12.98 | Low : | 3 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NTHI ] has closed above the upper band by 6.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 35% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.33 - 4.36 | 4.36 - 4.38 |
| Low: | 3.13 - 3.16 | 3.16 - 3.18 |
| Close: | 4.17 - 4.22 | 4.22 - 4.26 |
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Fri, 14 Aug 2026
NTHI: All proposals, including director elections and plan amendments, were approved without questions - TradingView
Thu, 13 Aug 2026
NeOnc Technologies holds investor call to discuss Phase 2a NEO100-01 results By Investing.com - Investing.com
Thu, 13 Aug 2026
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26 - TradingView
Thu, 13 Aug 2026
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26 - Yahoo Finance
Thu, 13 Aug 2026
NeOnc Technologies Holdings’ NEO100 Phase 2a Results Highlight Intranasal Brain-Delivery Platform Potential - Quiver Quantitative
Wed, 12 Aug 2026
NeOnc Technologies shares jump after positive Phase 2a glioma results - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 26 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 58.6 (%) |
| Held by Institutions | 11.8 (%) |
| Shares Short | 522 (K) |
| Shares Short P.Month | 271 (K) |
| EPS | -1.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.56 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -354.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -22 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -2.35 |
| PEG Ratio | 0 |
| Price to Book value | -7.68 |
| Price to Sales | 0 |
| Price to Cash Flow | -5.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|